Equity incl. NCI
Balance – as of period end · $M
Q1 2025
−978$M
All values (6)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 9,155 | reported |
| Q1 2026 | −195 | reported |
| Q4 2025 | −579 | reported |
| Q3 2025 | – | missing: No verified SEC value extracted, although the company reports this metric in other periods. |
| Q2 2025 | −651 | reported |
| Q1 2025 | −978 | reported |
| Q4 2024 | None | error |
| Q1 2016 – Q3 2024 | – | missing (35 periods): Grund wie bei Q3 2025. |
Show reported periods only · CSV with all sources · Technical ID: equity_total
More metrics for Cerebras
Income statement
Balance sheet
Debt and interest
Sources & calculation
- Value
- −$978M
- Period
- Q1 2025, ended Mar 31, 2025 · as of Mar 31, 2025 (balance as of date, not a sum)
- Source
- 10-Q, filed Jun 24, 2026 · 0001628280-26-044981
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | −$978M | Jun 24, 2026 | 10-Q 0001628280-26-044981 | reported · confidence 1. · current |